MedTrace Logo

Walnut Intervention on Metabolic Syndrome (WIMS)

NCT00742742 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2015-02-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether a daily supplement of 30 grams of walnut is effective in the treatment of metabolic syndrome (MetS).

Conditions

  • Metabolic Syndrome X

Interventions

BEHAVIORAL

healthy life style education

healthy life style education

Sponsors & Collaborators

  • California Walnut Commission

    collaborator OTHER

  • Chinese Academy of Sciences

    lead OTHER_GOV

Principal Investigators

  • Xu Lin, MD, PhD · Institute for Nutritional Sciecnes, Chinese Acadamy of Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-07-31
Completion
2009-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00742742 on ClinicalTrials.gov